跳至主要内容
临床试验/NCT03477825
NCT03477825已完成不适用

Pilot Study on the Effects of Oral Triphala and Rubia Cordifolia on the Gut Microbiome and Skin Biophysical Properties

University of California, Davis2 个研究点 分布在 1 个国家目标入组 35 人开始时间: 2018年3月12日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
35
试验地点
2
主要终点
Sebum excretion rate

研究概览

简要总结

Few studies have assessed the effects of Triphala and Rubia Cordifolia from a skin biophysical perspective. Here, we aim to understand how these herbs can modulate the skin's barrier properties and the gut microbiome.

详细描述

Herbal supplements such as Rubia cordifolia and Triphala [a mix of Emblica officinalis (Amalaki), Terminalia bellerica (Bibhitaki), and Terminalia chebula (Haritaki)] are commonly used for skin based treatments in India. However, the scientific evidence for their specific effects on the skin are scant. Rubia cordifolia is a root that is used in skin care for pigmentation and inflammation.1 Triphala is thought to have antioxidant properties and reduce inflammation in general. Herbs have been shown to modulate the gut microbiome, as previous studies have suggested that triphala may modify the gut microbiome.2

However, few studies have assessed the effects of these herbs from a skin biophysical perspective. Here, we aim to understand how these herbs can modulate the skin's barrier properties and the gut microbiome.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

盲法说明

Double blinded

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

Placebo

Placebo Comparator

Group A: Placebo group (n = 10)

  • Supplement appearing similar to Herbal formulations
  • Each placebo tablet will contain microcrystalline cellulose, dicalcium phosphate, PVPK30, sodium starch glycolate, magnesium stearate, OpaDry orange coating.
  • Dose: subjects in this group will take 4 placebo tablets per day

干预措施: Placebo Oral Tablet (Dietary Supplement)

Rubia Cordifolia

Experimental

Group B: R. cordifolia group (n = 10)

  • 2,000 mg R. cordifolia per day - supplied by Banyan Botanicals and following standard supplementation doses on commercially available supplement (https://www.banyanbotanicals.com/manjistha-tablets/)
  • Each tablet contains 500 mg of R. cordifolia per tablet.

干预措施: Rubia Cordifolia (Dietary Supplement)

Triphala

Experimental

Group C: Triphala group (n= 10)

  • Tablets of Triphala will be supplied from Banyan Botanicals (https://www.banyanbotanicals.com/triphala-tablets-11/)
  • Each tablet contains mix Emblica officinalis, Terminalia bellerica, and Terminalia chebula
  • Dose: subjects will take 4 tablets per day, with a total dose of 2,000 mg of total herb.

干预措施: Triphala (Dietary Supplement)

结局指标

主要结局

Sebum excretion rate

时间窗: 4 weeks +/- 1 week

Sebum production measured by sebumeter

Stool microbiome diversity via stool sample

时间窗: 4 weeks +/- 1 week

Stool microbiome diversity via stool sample

次要结局

  • Transepidermal water loss via Tewameter(4 weeks +/- 1 week)
  • Facial brightness measured via photographic assessment(4 weeks +/- 1 week)
  • Facial wrinkles via photographic assessment(4 weeks +/- 1 week)
  • Facial shine via photographic assessment(4 weeks +/- 1 week)
  • Digestion Questionnaire(4 weeks +/- 1 week)
  • Facial redness via photographic assessment(4 weeks +/- 1 week)
  • Symptoms Questionnaire(4 weeks +/- 1 week)
  • Food Intake Log(4 weeks +/- 1 week)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Pilot Study of Triphala and Rubia Cordifolia on Gut... | 临床试验